Bovine Serum Laboratories manufactures the bovine serum vaccine reagents distributed by Genprice. The Bovine Serum Vaccine reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Bovine Serum. Other Bovine products are available in stock. Specificity: Bovine Category: Serum Group: Vaccine
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
The Native Antigen Company |
0.5ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 12 months post immunisation |
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 12 months post immunisation |
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of the Japanese Encephalitis Virus vaccine (IXIARO (Strain SA14)), 6 months post immunisation. |
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of the Japanese Encephalitis Virus vaccine (IXIARO (Strain SA14)), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: 2 Week (IgM) Bleed |
|
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 2 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 2 Week (IgM) Bleed |
|
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 2 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: Vaccination Time-Course Panel |
|
The Native Antigen Company |
3x1ml |
EUR 1538.64 |
|
Description: Triple pack of samples from an individual who was immunised with theYellow Fever vaccine Stamaril (17D strain). The first vial is a pre-bleed sample, taken one week before the immunisation. The second vial is an “IgM” vial, taken 2 weeks post immunisation. The third vial is an “IgG” vial taken 6weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: Vaccination Time-Course Panel |
|
The Native Antigen Company |
3x0.5ml |
EUR 1005.59 |
|
Description: Triple pack of samples from an individual who was immunised with theYellow Fever vaccine Stamaril (17D strain). The first vial is a pre-bleed sample, taken one week before the immunisation. The second vial is an “IgM” vial, taken 2 weeks post immunisation. The third vial is an “IgG” vial taken 6weeks post immunisation. |
Vaccine information
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|
SER71210-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of the Japanese Encephalitis Virus vaccine (IXIARO (Strain SA14)), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|
SER71206-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|
SER71206-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71200-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71200-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71207-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71207-500 |
The Native Antigen Company |
0.5ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Serum |
|
ISERSCOV2VPP |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Serum |
Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Serum |
|
MBS8434697-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Single Donor Human SARS-Cov-2 Presumptive Non-Placebo Vaccine Positive Serum |
|
ISERSCOV2PNPP100UL |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human SARS-Cov-2 Presumptive Non-Placebo Vaccine Positive Serum |
Single Donor Human SARS-Cov-2 Presumptive Non-Placebo Vaccine Positive Serum |
|
MBS8421603-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Serum |
|
ISERSCOV2VNP1BPIMCMP |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Serum |
Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Serum |
|
MBS8434696-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Rotavirus vaccine |
|
VAC-0352 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
|
Description: Protein |
Vaccine adjuvant-1 |
|
HY-160198 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Vaccine adjuvant-1 is an vaccine adjuvant is a vaccine adjuvant containing an oil phase, emulsifying agent and water[1]. |
Hepatitis A Vaccine |
|
SARS-401 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
Yellow Fever Vaccine |
|
VAC-0339 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
|
Description: Protein |
Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvant |
|
AV-7010-50 |
Alpha Diagnostics |
50 ug |
EUR 1074 |
Rubella Virus Vaccine |
|
VAC-0323 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
|
Description: Protein |
Smallpox (Vaccinia) Vaccine, Live |
|
VLP-353 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |